A股大医药概念集体回升，重组蛋白、CRO、生物制品、创新药等概念跌幅均有收窄；锦波生物涨超3%，上海莱士、万泰生物、毕得医药等个股跟涨。特朗普此前宣布，药品关税可能高达200%。

Group 1 - The A-share pharmaceutical sector has collectively rebounded, with concepts such as recombinant proteins, CRO, biopharmaceuticals, and innovative drugs showing reduced declines [1] - Jinbo Bio has seen an increase of over 3%, with stocks like Shanghai Laishi, Wantai Bio, and Bid Pharma also experiencing gains [1] - Trump previously announced that drug tariffs could reach as high as 200% [1]